ACD/Labs, an informatics company that develops and commercializes software in support of digitalized R&D, today announces the release of a new two-part white paper series, AI-Digital-Physical Convergence: The Future of DMTA in Drug Discovery and Development. The series explores how pharmaceutical organizations can accelerate innovation by modernizing the design-make-test-analyze (DMTA) cycle through AI applications and scientific software working in concert with scientists and the physic…
Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=344359
